A
Armata Pharmaceuticals, Inc. (ARMP)
ASE – Real Time Price. Currency in USD
7.40
+0.90 (13.85%)
At close: Jun 26, 2026, 4:00 PM EDT
7.40
0.00 (0.00%)
After-hours: Jun 26, 2026, 6:01 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
7.40
+0.90 (13.85%)
At close: Jun 26, 2026, 4:00 PM EDT
7.40
0.00 (0.00%)
After-hours: Jun 26, 2026, 6:01 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $373.7M significantly exceeds cash reserves ($4.8M), raising financial stability concerns
Total current liabilities $9.2M surpass Total current assets $5.9M, signaling liquidity issues
Debt-to-equity ratio (-1.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$5.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.64 | 6.05 | 4.0 | |
| Quick ratio | 0.64 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 5.35 | 1.04 | 1.0 | |
| Interest coverage | -1.58 | -16.91 | 1.0 | |
| Weighted average score | 2.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 6M | 5M | 5M | 5M | 5M |
| Gross Profit | 5M | 4M | 4M | 3M | 4M |
| Operating Income | -37M | -41M | -42M | -31M | -32M |
| Net Income | -37M | -69M | -19M | -174M | -283M |
| EBITDA | -36M | -40M | -41M | -30M | -30M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -80.64 | 1.11 | 2.0 |
| Next quarter | -61.17 | 47.3 | 5.5 |
| Current year | -55.14 | 20.73 | 5.5 |
| Next year | 25 | 64.78 | 10 |
| Weighted average score | 5.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -27.27 | 7.2 | 7.6 | 13.1 | 5.0 |
| Y/Y | 60.69 | -1666.12 | -1479.99 | 23.88 | 5.5 |
| 3y average | -2.9 | -277.72 | -154.24 | 0.72 | 1.3 |
| 5y average | 91.6 | -179.39 | -89.26 | -13.5 | 3.3 |
| Weighted average score | 3.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |